Pemphigus Vulgaris or Foliaceus Research Study

Adults aged 18-80 years old with moderate to severe pemphigus vulgaris or foliaceus, may qualify to participate. This study is open to both relapsing patients (diagnosed more than 6 months prior to screening) and newly diagnosed patients (diagnosed 6 months or less prior to screening). A body mass index (BMI) of 17.5 or more is required.

Participants will receive investigational oral medication (active study drug) or placebo, and a corticosteroid (prednisone or prednisolone) during the initial treatment period. During the extension period, all individuals will receive active study drug, and a corticosteroid. Study medication and study-related care will be provided at no cost. Reimbursement for study-related travel expenses may be provided.

Study participation will last about 68 weeks and involve about 19 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Pemphigus Vulgaris
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Similar Studies

  • At this time there are no other studies for this condition. Please register to be contacted about upcoming studies for this condition.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more